Navigation Links
Ardea Biosciences Provides Additional Results From a Phase 2b Study of Lesinurad in Combination With Allopurinol at the Annual European Congress of Rheumatology
Date:5/25/2011

ary benefit for gout patients taking this common treatment for hypertension.  Consistent with these preclinical results, a high level of response was observed with lesinurad in the subset of patients receiving thiazide diuretics in study 203.

Results Presented from Phase 1b Study Evaluating the Combination of Lesinurad and Febuxostat

Final results were also presented from a completed Phase 1b study evaluating the combination of lesinurad and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen and Menarini) in gout patients with sUA of at least 8 mg/dL.

In this Phase 1b clinical study evaluating the use of lesinurad in combination with febuxostat in 21 gout patients, 100 percent of patients receiving the combination achieved sUA levels below 6 mg/dL, compared to 67 percent and 56 percent for patients receiving 40 mg and 80 mg, respectively, of febuxostat alone. With the highest dose of febuxostat combined with either 400 mg or 600 mg lesinurad, 100 percent of patients reached sUA levels below 4 mg/dL.  No patient achieved these reduced sUA levels on this dose of febuxostat alone. The combination of lesinurad and febuxostat was well tolerated with no serious adverse events or discontinuations due to adverse events.

"While the 28-day results from our 203 Study were encouraging, the high rate of sustained uric acid lowering achieved during the extension period, using the lower doses of lesinurad, are even more impressive," said Barry D. Quart, PharmD, President and Chief Executive Officer of Ardea Biosciences. "Continued dosing with 200 mg produced results similar to those seen at 28 days with higher doses, giving us a wide range of doses to consider for the Phase 3 program."

EULAR Posters and Presentations

Ardea's presentation and posters presented at EULAR are available on the Company's website (www.ardeabio.com) un
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
11. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... FRANKLIN LAKES, N.J. , March 26, 2015 /PRNewswire/ ... announced today that it will commence offers to exchange ... series issued by CareFusion Corporation, a wholly owned subsidiary ... as described in the table below. A Registration Statement ... issuance of the New Notes was filed with the ...
(Date:3/26/2015)... Fla. , March 26, 2015 /PRNewswire/ ... subsidiary of Oxis International, Inc. [OTC: OXIS] ... execution of an exclusive option agreement with ... patents/intellectual properties developed by Dr. Xiang-Qun ... and Professor, Pharmaceutical Sciences, School of Pharmacy.  ...
(Date:3/26/2015)... CAMBRIDGE, Mass. , March 26, 2015 ... today announced that it will present preclinical ... pipeline at the 2015 American Association for ... April 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia. The ... antibody engineering and nanoliposomal technology platforms, as ...
Breaking Medicine Technology:Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 3
... DETROIT, Feb. 14, 2012  The U.S. Food and Drug ... Ingredients (APIs).  If an API does not maintain adequate ... FDA will consider the material to be misbranded.  Foreign ... physical examination under FDA,s Import Alert 66-66 "Red List." ...
... 14, 2012  GHX today announced that the company has ... from Implanet. The acquisition is the latest move by ... the industry,s first comprehensive supply chain solution for physician ... were not disclosed. The GHX implantable device ...
Cached Medicine Technology:FDA Grants Petition for Removal From Import Alert 2GHX Acquires Beep N Track to Accelerate Delivery of Healthcare Industry's First Implantable Device Supply Chain Solution 2GHX Acquires Beep N Track to Accelerate Delivery of Healthcare Industry's First Implantable Device Supply Chain Solution 3GHX Acquires Beep N Track to Accelerate Delivery of Healthcare Industry's First Implantable Device Supply Chain Solution 4GHX Acquires Beep N Track to Accelerate Delivery of Healthcare Industry's First Implantable Device Supply Chain Solution 5
(Date:3/26/2015)... Dr. Rod J. Rohrich, who served ... and has trained over 6500 surgeons through these ... based medicine (EBM), that is, the optimization of decision ... "We often hear from rhinoplasty surgeons who ... certainly not trying to stifle these discussions, we do ...
(Date:3/26/2015)... 2015 Florida Hospital teamed up with ABC ... Health campaign and live Dr. Oz event, which took place ... More than a thousand people came out to see Dr. ... , The world renowned cardiothoracic surgeon and Emmy award winning ... and a panel of experts for the live health expo. ...
(Date:3/26/2015)... Old Tappan, NJ (PRWEB) March 26, 2015 ... research and statistical consulting firm, announced the release of ... by health experts to increase access to public restrooms ... recent trends in bathroom apps, BathroomMap does not facilitate ... a proprietary algorithm to identify and rate local establishments ...
(Date:3/26/2015)... Frencisco, CA (PRWEB) March 26, 2015 ... Center are proud to announce expanded offerings for Bay ... San Francisco Dental Implant Center has long been a ... have expanded its offerings to meet the strong demand ... in our reputation as a top-rated dental implant facility ...
(Date:3/26/2015)... On March 5, 2015, Portland Trail ... for the season with a torn Achilles tendon in ... Blazers were competing against Dallas, and was confirmed via ... Silva, M.D., who has treated many professional athletes, voiced ... could be prevented. , "Part of the problem ...
Breaking Medicine News(10 mins):Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 2Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 4
... Institute of Medicine it was found that fat formed more that ... balanced diet which in turn results in various ill effects. About ... from fat which is the main cause of various health risks. ... questioned them about their food habits. ,Statistics Canada released ...
... goes flip flop due to a variety of reasons. Mental ... economic outlay for mental healthcare is to the tune of ... of unemployment, family troubles, crime and suicide attempts. The quality ... for the children, prisoners and those without homes, which ...
... a large quantity of spurious drugs and arrested one person ... of costly life-saving medicines//. ,Acting on a tip-off, ... and seized the spurious medicines. The owner of the store ... the fake medicines, whose genuine versions would have been worth ...
... identified in the brain of patients suffering from mild ... of MCI to Alzheimer’s disease (AD) dementia//, according to ... of Aging. ,Researchers at Mount Sinai School ... dementia may be delayed by eliminating plaque causing beta-amyloid ...
... people today formed a human chain to show their solidarity ... college. This was an initiative to raise the college's present ... All India Institute of Medical Sciences. // ... people and students, stretched to three kilometres from Chattiram to ...
... for their aches and pains could be at an ... of a new study// . ,Researchers said ... dose of acetaminophen showed abnormalities in blood tests, which ... had come across liver damage in patients who took ...
Cached Medicine News:Health News:Discovery of Elevated Amyloid Peptide levels could lead to Alzheimer’s Preventio 2Health News:Even Normal Doses Of Tylenol Could Damage Liver 2
... Single Use reloadable linear stapler with titanium ... disposable stapler is designed for use in ... internal tissues. The instrument places a double ... using the 30 VASCULAR cartridges) of titanium ...
... The ILA™ 75 single-use stapler, ... in the resection, transection, and/or the ... ,INDICATIONS The ILA™ 75 single-use ... use in the resection, transection, and/or ...
... PROXIMATE ILS Staplers are anastomotic staplers available ... of instrument to lumen diameter. The staplers ... head to improve access and ease of ... control tissue compression by adjusting the height ...
ENDOPATH ILS Circular Sizer Set for ILS circular staplers. , ,The ILS Circular Sizer Set is intended to aid in selecting the appropriate size ILS Intraluminal Stapler for use in a variety of applica...
Medicine Products: